Today: 7 July 2026
Ondas Inc. (NASDAQ:ONDS) heads into shortened week after 315 million shares trade
7 July 2026
2 mins read

Ondas stock gains after DZYNE deal, share supply in focus

NEW YORK, July 7, 2026, 07:04 (EDT)

  • Ondas ended Monday at $7.82, gaining 5.53% as 73.39 million shares changed hands. The stock was trading around $7.84 in early pre-market Tuesday.
  • The DZYNE deal brings in around 85 million shares, with 45 million of them delayed and locked up for six months.
  • Ondas lifted its 2026 revenue goal to a minimum of $525 million, up from the prior $390 million target.
  • Analysts now put the average price target at $20.13, according to the latest table. The targets run from $16 up to $25.

Ondas Inc. goes into Tuesday’s pre-market with the focus more on how soon the new shares will be available, not just the size of the DZYNE Technologies acquisition the company just did with stock.

The stock finished Monday at $7.82, up 5.53%. The S&P 500 gained 0.72%. Volume came in at 73.39 million shares, beating the 65-day average of 68.20 million. In pre-market trade Tuesday, the stock was at $7.8399 at 7:01 a.m. EDT. FactSet data from WSJ put short interest at 167.52 million shares, or 32.70% of the float.

Ondas said Monday it bought DZYNE for $875.8 million. The deal includes $200 million in cash and around 85 million Ondas shares, worth close to $675 million. According to an SEC filing, 45 million of those shares have a six-month lock-up.

The filing tacks on another restriction—each seller can only sell up to their portion of 10% of daily trading volume. Based on Monday’s activity, that sets the limit at around 7.3 million shares before splits between the sellers, well under a tenth of the full allotment. It’s a notable point, since Ondas has a high short interest and the share count keeps changing fast.

Eric Brock, who is chairman and CEO at Ondas, said the military edge now goes to companies able to roll out autonomous systems in large numbers. Jeff Hull, the president and chief executive at Highlander Partners, DZYNE’s majority owner, said the sellers opted for mostly Ondas equity, pointing to what he called “long-term value” in the merged business.

The updated guidance shifts the numbers. Ondas bumped its 2026 revenue goal up to at least $525 million from a previous $390 million minimum. DZYNE is set to deliver $191 million in revenue for 2026, topping $300 million the next year, with 2027 EBITDA margin aiming for the mid-teens and mid-20% range the year after.

Forecast itemPrior / baseNew or current figureChange
Ondas is now aiming for at least $525 mln revenue in 2026, up from $390 mln beforeAt least $390 mlnAt least $525 mlnAt least +$135 mln
DZYNE’s 2026 revenue is now forecast at $191 mln, added after the dealN/A$191 mlnAdded with deal
DZYNE is guiding for 2027 revenue above $300 mlnN/AMore than $300 mlnCompany forecast
DZYNE’s 2027 EBITDA margin is targeted in the mid-teensN/AMid-teensCompany forecast
For 2028, DZYNE is aiming at an EBITDA margin in the mid-20% rangeN/AMid-20% rangeCompany forecast

DZYNE’s 2026 revenue forecast doesn’t line up exactly with the new Ondas outlook. The updated target folds in both DZYNE and Omnisys, after that deal closed on May 21. It leaves out Cyberhawk, with Ondas saying it plans to finish that deal in the third quarter. Investors are left figuring out how much of the 2026 guidance depends on timing, what’s already in the backlog, and what still needs new orders later in the year.

Ondas’ latest investor deck quoted DZYNE’s backlog at $111 million at June 30, with a three-year pipeline pegged above $1.5 billion. The filing also said DZYNE aims to ship as many as eight ULTRA systems in 2026, up to 20 in 2027, and remains on pace to deliver over 750 IonStrike systems in 2026.

Analyst price targets stay above current levels. StockAnalysis, using S&P Global numbers, lists eight analysts on a “Strong Buy” call. The average 12-month target is $20.13, median $19.50, low is $16, high at $25. Needham’s Austin Bohlig is at $19 as of July 7, cut from $23. Lake Street’s Max Michaelis is also at $19 on July 6. StockAnalysis

Analyst / sourceLatest ratingLatest targetDate
Austin Bohlig at NeedhamBuy$19July 7, 2026
Max Michaelis from Lake StreetBuy$19July 6, 2026
Michael Latimore with Northland SecuritiesBuy$18June 18, 2026
S&P Global averageStrong Buy consensus$20.13Current table

Nasdaq has July 3 down as the 2026 Independence Day market holiday, not July 7. Regular hours are 9:30 a.m. to 4:00 p.m. Eastern, and pre-market opens at 4:00 a.m.

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets.

Stock Market Today

  • Profound Medical (PROF) Gains 8.2% as Trading Picks Up, EPS Views Unchanged
    July 7, 2026, 9:09 AM EDT. Profound Medical (PROF) finished up 8.2% at $7.37 as momentum buyers moved into small-cap medtech names and volumes increased. The stock ran with no new developments out of the company and no changes to earnings per share estimates. Investors stayed positive on Profound's 2026 outlook and its commercial rollout. The group is expected to post a quarterly loss of $0.22 a share, narrowing 57.7% from last year, while revenue could climb 153.4% to $5.6 million. PROF carries a Zacks Rank #3 (Hold). With EPS estimates steady, traders are watching to see if the move will hold.
Intel (NASDAQ:INTC) stock sees quick turnover as traders exit ahead of Q2 results
Previous Story

Intel dips before the bell despite higher EPS estimates

Grab gains as Stash deal brings in fintech boost, Vietnam clock ticking
Next Story

Grab (NASDAQ:GRAB): Board departure renews focus on Taiwan, cash position and targets

Go toTop